According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.38 Billion. In 2023 the company made an earning of -NZ$0.39 Billion, an increase over its 2022 earnings that were of -NZ$0.42 Billion. The earnings displayed on this page is the company's Pretax Income.